Antibe Therapeutics Inc (ATBPF)
0.2156
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Antibe Therapeutics Price to Book Value: 0.5808 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 0.5808 |
| May 03, 2024 | 0.5808 |
| May 02, 2024 | 0.5808 |
| May 01, 2024 | 0.5808 |
| April 30, 2024 | 0.5808 |
| April 29, 2024 | 0.5808 |
| April 26, 2024 | 0.5808 |
| April 25, 2024 | 0.5808 |
| April 24, 2024 | 0.5808 |
| April 23, 2024 | 0.5808 |
| April 22, 2024 | 0.5808 |
| April 19, 2024 | 0.5808 |
| April 18, 2024 | 0.5808 |
| April 17, 2024 | 0.5808 |
| April 16, 2024 | 0.5808 |
| April 15, 2024 | 0.5808 |
| April 12, 2024 | 0.5808 |
| April 11, 2024 | 0.5808 |
| April 10, 2024 | 0.5808 |
| April 09, 2024 | 0.5808 |
| April 08, 2024 | 0.5808 |
| April 05, 2024 | 0.5118 |
| April 04, 2024 | 0.5619 |
| April 03, 2024 | 0.5231 |
| April 02, 2024 | 0.3658 |
| Date | Value |
|---|---|
| April 01, 2024 | 0.3106 |
| March 28, 2024 | 0.901 |
| March 27, 2024 | 0.8573 |
| March 26, 2024 | 0.8709 |
| March 25, 2024 | 0.835 |
| March 22, 2024 | 0.835 |
| March 21, 2024 | 0.8474 |
| March 20, 2024 | 0.8235 |
| March 19, 2024 | 0.826 |
| March 18, 2024 | 0.8631 |
| March 15, 2024 | 0.8752 |
| March 14, 2024 | 0.8989 |
| March 13, 2024 | 0.9649 |
| March 12, 2024 | 0.9229 |
| March 11, 2024 | 0.862 |
| March 08, 2024 | 0.9075 |
| March 07, 2024 | 1.050 |
| March 06, 2024 | 1.045 |
| March 05, 2024 | 1.067 |
| March 04, 2024 | 1.050 |
| March 01, 2024 | 1.969 |
| February 29, 2024 | 1.925 |
| February 28, 2024 | 1.935 |
| February 27, 2024 | 1.980 |
| February 26, 2024 | 2.082 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3106
Minimum
Apr 01 2024
63.37
Maximum
May 29 2020
7.242
Average
1.339
Median
Nov 27 2023
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4287 |
| Aurinia Pharmaceuticals Inc | 1.953 |
| Edesa Biotech Inc | 2.485 |
| Lexaria Bioscience Corp | 6.699 |
| InMed Pharmaceuticals Inc | 0.1213 |
Price to Book Value Related Metrics
| Price | 0.2156 |
| Earnings Yield | -120.3% |
| Market Cap | 11.35M |